EUVIMEDEUVIMED entdecken
Open Access

Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism

Matthew D Ettleson iD, Sabrina Ibarra, Wen Wan, Sarah Peterson, Neda Laiteerapong iD, Antonio C Bianco iD

The Journal of Clinical Endocrinology & Metabolism · 2023

DOI: 10.1210/clinem/dgad331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Matthew D Ettleson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: Hypothyroidism. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NIH HHS, National Institute of Diabetes and Digestive and Kidney Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Clinical guidelines have recommended a trial of liothyronine (LT3) with levothyroxine (LT4) in select patients with hypothyroidism. However, little is known about the real-world use of LT3 and desiccated thyroid extract (DTE) and the characteristics of patients treated with LT3 and DTE.

Objectives

(1) Determine national trends of new LT4, LT3, and DTE prescriptions in the United States; (2) determine whether sociodemographic, healthcare access, and dietary factors are associated with different thyroid hormone (TH) therapies.

Methods

Parallel cross-sectional studies were conducted using 2 datasets: (1) a national patient claims dataset (2010-2020) and (2) the National Health and Nutrition Examination Study (NHANES) dataset (1999-2016). Included participants had a diagnosis of primary or subclinical hypothyroidism. Study outcomes included the impact of demographics and healthcare access on differences in the proportion of TH therapies consisting of LT4, LT3, and DTE (patient claims) and differences in dietary behaviors between DTE-treated participants and LT4-treated matched controls (NHANES).

Results

On an average annual basis, 47 711 adults received at least 1 new TH prescription, with 88.3% receiving LT4 monotherapy, 2.0% receiving LT3 therapy, and 9.4% receiving DTE therapy. The proportion receiving DTE therapy increased from 5.4% in 2010 to 10.2% in 2020. In the analysis between states, high primary care and endocrinology physician densities were associated with increased use of LT4 monotherapy (odds ratio 2.51, P < .001 and odds ratio 2.71, P < .001). DTE-treated NHANES participants (n = 73) consumed more dietary supplements compared to LT4-treated participants (n = 146) (4.7 vs 2.1, P < .001).

Conclusions

The proportion of new TH therapies containing DTE for hypothyroidism doubled since 2010 while LT3 therapies remained stable. DTE treatment was associated with decreased physician density and increased dietary supplement use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothyroidismAdultHumansNutrition SurveysCross-Sectional StudiesThyroxineTriiodothyronineThyroid HormonesDemography

Stichwörter der Autor:innen

desiccated thyroid extractdietary supplementsgeographic trendshypothyroidismlevothyroxine

Substanzen

ThyroxineTriiodothyronineThyroid Hormones

Autor:innen und Institutionen

  • Department of Medicine, Section of Endocrinology, Diabetes, and Metabolism, University of Chicago, Chicago, IL 60637, USA.
  • Department of Medicine, Section of General Internal Medicine, University of Chicago, Chicago, IL 60637, USA.
  • Department of Clinical Nutrition, Rush University Medical Center, Chicago, IL 60612, USA.

ORCID-Profile: Matthew D Ettleson, Neda Laiteerapong, Antonio C Bianco

Förderung

  • NIDDK NIH HHS
  • NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Disease
  • National Institutes of Health

Zitieren

APA

Ettleson, M. D., Ibarra, S., Wan, W., Peterson, S., Laiteerapong, N., & Bianco, A. C. (2023). Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad331

Vancouver

Ettleson MD, Ibarra S, Wan W, Peterson S, Laiteerapong N, Bianco AC. Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad331

BibTeX
@article{Ettleson2023,
  author = {Ettleson, Matthew D and Ibarra, Sabrina and Wan, Wen and Peterson, Sarah and Laiteerapong, Neda and Bianco, Antonio C},
  title = {Demographic, Healthcare Access, and Dietary Factors Associated With Thyroid Hormone Treatments for Hypothyroidism},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  doi = {10.1210/clinem/dgad331}
}
Kostenlos starten →